| 000 | 01885 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250515160740.0 | ||
| 264 | 0 | _c20090609 | |
| 008 | 200906s 0 0 eng d | ||
| 022 | _a1528-0020 | ||
| 024 | 7 |
_a10.1182/blood-2008-10-183392 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGaidzik, Verena Ingeborg | |
| 245 | 0 | 0 |
_aPrognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group. _h[electronic resource] |
| 260 |
_bBlood _cMay 2009 |
||
| 300 |
_a4505-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aAustria |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aCytogenetic Analysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGermany |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTandem Repeat Sequences _xgenetics |
| 650 | 0 | 4 |
_aWT1 Proteins _xgenetics |
| 650 | 0 | 4 | _aYoung Adult |
| 650 | 0 | 4 |
_afms-Like Tyrosine Kinase 3 _xgenetics |
| 700 | 1 | _aSchlenk, Richard Friedrich | |
| 700 | 1 | _aMoschny, Simone | |
| 700 | 1 | _aBecker, Annegret | |
| 700 | 1 | _aBullinger, Lars | |
| 700 | 1 | _aCorbacioglu, Andrea | |
| 700 | 1 | _aKrauter, Jürgen | |
| 700 | 1 | _aSchlegelberger, Brigitte | |
| 700 | 1 | _aGanser, Arnold | |
| 700 | 1 | _aDöhner, Hartmut | |
| 700 | 1 | _aDöhner, Konstanze | |
| 773 | 0 |
_tBlood _gvol. 113 _gno. 19 _gp. 4505-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2008-10-183392 _zAvailable from publisher's website |
| 999 |
_c18664003 _d18664003 |
||